Effects of Medicaid Coverage and State-Level Delivery Approaches on Healthcare Quality, Outcomes, and Costs for Adults with Diabetes
医疗补助覆盖范围和州级交付方法对成人糖尿病患者的医疗质量、结果和成本的影响
基本信息
- 批准号:10097549
- 负责人:
- 金额:$ 44.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2025-09-29
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
Despite tremendous advances in diabetes, many Americans continue to have poor control over risk factors
such as blood glucose, blood pressure, and cholesterol. As a result, diabetes continues to be a leading cause
of death and many preventable complications, such as heart disease, stroke, chronic kidney disease, visual
loss, and amputation. Many adults with diabetes still lack access to a coordinated healthcare team and do not
complete evidence-based preventive services, receive medications or technologies that may improve disease
care, participate in self-management behaviors, or follow-up for early detection and treatment of comorbidities
and complications. This gap between evidence and practice disproportionately impacts the aged, those with
disabilities, and the poor. As the primary health insurer for these vulnerable groups, Medicaid policies that
expand eligibility requirements or lower barriers for initiating high value medications have the potential to
improve healthcare engagement, delivery, and outcomes. States have a great deal of flexibility in administering
Medicaid programs, and the Affordable Care Act and other health reforms further catalyzed state-level
variation in eligibility, coverage, population management services, and financing. This variation presents a
tremendous opportunity for natural experiments to evaluate the comparative effectiveness and costs of policy
shifts on the care and outcomes of diabetes in vulnerable groups for whom the burden of diabetes is highest.
We propose a Natural Experimental Research Center that will evaluate: 1) health and economic effects of
state-specific variation in Medicaid managed care approaches for pharmacy utilization management affecting a
newer class of diabetes medications with high costs but unique benefits: SGLT2 inhibitors; and 2) the medium-
to longer-term effects of ACA expansion of health insurance coverage for adults with diabetes. We will
leverage our access to two unique longitudinal datasets: (i) national claims data from UnitedHealth Group, a
major Medicaid managed care provider for 6 million people in 27 states; and (ii) multi-state (Illinois, Indiana,
Wisconsin) electronic heath records linked to Medicaid and Medicare claims. Outcomes of interest will include
medication adherence, diabetes care quality, cardiometabolic risk factor control, acute diabetes complications,
other forms of healthcare utilization, and costs. To evaluate state policies for medication utilization
management, we will use difference-in-differences designs involving matched comparators in states with
different policies. We will use the linked EHR-claims data from three states in novel, hybrid regression
discontinuity (RD) and DiD designs to study the longer-term effects of ACA insurance expansion.
Through direct engagement of collaborators and data contributors in participating states, our studies have
been designed around high priority questions involving the effectiveness of particular programs. These studies
are of high interest to state Medicaid programs and their managed care partners in all states, and our results
will be communicated to them to guide policy decisions and to facilitate new natural experiments in the future.
项目摘要
尽管在糖尿病方面取得了巨大的进步,但许多美国人仍然对风险因素控制不力
例如血糖、血压和胆固醇。因此,糖尿病仍然是一个主要原因,
死亡和许多可预防的并发症,如心脏病,中风,慢性肾脏疾病,视力
丧失和截肢许多成年糖尿病患者仍然无法获得协调的医疗团队,
完成循证预防服务,接受可能改善疾病的药物或技术
护理,参与自我管理行为,或随访以早期发现和治疗合并症
和并发症。证据和实践之间的这种差距不成比例地影响了老年人,
残疾人和穷人。作为这些弱势群体的主要健康保险人,医疗补助政策,
扩大资格要求或降低启动高价值药物的门槛有可能
改善医疗保健参与、交付和结果。各州在管理方面有很大的灵活性
医疗补助计划、平价医疗法案和其他医疗改革进一步催化了州一级的医疗改革。
资格、覆盖面、人口管理服务和筹资方面的差异。这种变化呈现出一种
自然实验评估政策的相对有效性和成本的巨大机会
糖尿病负担最重的弱势群体的糖尿病护理和结果发生变化。
我们建议建立一个自然实验研究中心,评估:1)
医疗补助管理式医疗保健方法在药房利用管理方面的州特异性变化
成本高但获益独特的新型糖尿病药物:SGLT 2抑制剂;和2)中等-
ACA扩大成人糖尿病健康保险覆盖范围的长期影响。我们将
利用我们对两个独特的纵向数据集的访问:(i)来自UnitedHealth Group的国家索赔数据,
在27个州为600万人提供主要的医疗补助管理护理提供者;以及(ii)多州(伊利诺伊州,印第安纳州,
威斯康星州)与医疗补助和医疗保险索赔有关的电子健康记录。感兴趣的结果将包括
药物依从性、糖尿病护理质量、心脏代谢风险因素控制、急性糖尿病并发症,
其他形式的医疗保健利用和成本。评估国家药物使用政策
管理,我们将使用差异中的差异设计,涉及在以下状态中匹配的比较器:
不同的政策。我们将在新的混合回归中使用来自三个州的相关EHR索赔数据
不连续性(RD)和DiD设计,以研究ACA保险扩张的长期影响。
通过参与国的合作者和数据贡献者的直接参与,我们的研究
是围绕着涉及特定项目有效性的高优先级问题设计的。这些研究
对所有州的州医疗补助计划及其管理式医疗合作伙伴都很感兴趣,我们的结果
将向他们传达这些信息,以指导政策决定,并促进未来新的自然实验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald T. Ackermann其他文献
The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes
- DOI:
10.1016/j.cct.2015.10.011 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
Alberly Perez;Victor A. Alos;Adam Scanlan;Catarina M. Maia;Adam Davey;Robert C. Whitaker;Gary D. Foster;Ronald T. Ackermann;Matthew J. O'Brien - 通讯作者:
Matthew J. O'Brien
Characteristics and Acute Care Utilization in Patients with Food Insecurity by Z Code Assignment from a Large Private Health Plan: A Longitudinal Analysis
- DOI:
10.1007/s11606-024-09261-0 - 发表时间:
2024-12-20 - 期刊:
- 影响因子:4.200
- 作者:
Jenny Jia;Raymond H. Kang;Manisha Cherupally;David T. Liss;Ronald T. Ackermann;Matthew J. O’Brien - 通讯作者:
Matthew J. O’Brien
Evidence and Challenges for Translation and Population Impact of the Diabetes Prevention Program
- DOI:
10.1007/s11892-020-1293-4 - 发表时间:
2020-02-20 - 期刊:
- 影响因子:6.400
- 作者:
Ronald T. Ackermann;Matthew J. O’Brien - 通讯作者:
Matthew J. O’Brien
Rational treatment choices for non-major depressions in primary care
- DOI:
10.1046/j.1525-1497.2002.10350.x - 发表时间:
2002-04-01 - 期刊:
- 影响因子:4.200
- 作者:
Ronald T. Ackermann;John W. Williams - 通讯作者:
John W. Williams
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
美国糖尿病预防计划随机临床试验中,生活方式和二甲双胍干预对 21 年以上 2 型糖尿病发病率的长期影响和效应异质性
- DOI:
10.1016/s2213-8587(25)00022-1 - 发表时间:
2025-06-01 - 期刊:
- 影响因子:41.800
- 作者:
William C Knowler;Lindsay Doherty;Sharon L Edelstein;Peter H Bennett;Dana Dabelea;Mary Hoskin;Steven E Kahn;Rita R Kalyani;Catherine Kim;F Xavier Pi-Sunyer;Sridharan Raghavan;Vallabh O Shah;Marinella Temprosa;Elizabeth M Venditti;David M Nathan;Caroline Abbas;Kathy Abbott;Solome Abebe;Ronald T. Ackermann;Kelly J. Acton;Joel Zonszein - 通讯作者:
Joel Zonszein
Ronald T. Ackermann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald T. Ackermann', 18)}}的其他基金
A Sentinel Network for Evaluation of the Reach, Implementation, Effectiveness, and Costs of Evidence-Based Lifestyle Interventions to Prevent Type 2 Diabetes in U.S. Adults
用于评估预防美国成人 2 型糖尿病的循证生活方式干预措施的范围、实施、有效性和成本的哨兵网络
- 批准号:
10662397 - 财政年份:2022
- 资助金额:
$ 44.62万 - 项目类别:
A Sentinel Network for Evaluation of the Reach, Implementation, Effectiveness, and Costs of Evidence-Based Lifestyle Interventions to Prevent Type 2 Diabetes in U.S. Adults
用于评估预防美国成人 2 型糖尿病的循证生活方式干预措施的范围、实施、有效性和成本的哨兵网络
- 批准号:
10554915 - 财政年份:2022
- 资助金额:
$ 44.62万 - 项目类别:
COllaborative Northwestern Surgical Oncology Research Training (CONSORT)
西北大学肿瘤外科研究合作培训 (CONSORT)
- 批准号:
10656448 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别:
Effects of Medicaid Coverage and State-Level Delivery Approaches on Healthcare Quality, Outcomes, and Costs for Adults with Diabetes
医疗补助覆盖范围和州级交付方法对成人糖尿病患者的医疗质量、结果和成本的影响
- 批准号:
10223857 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别:
COllaborative Northwestern Surgical Oncology Research Training (CONSORT)
西北大学肿瘤外科研究合作培训 (CONSORT)
- 批准号:
10442378 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别:
Effects of Medicaid Coverage and State-Level Delivery Approaches on Healthcare Quality, Outcomes, and Costs for Adults with Diabetes
医疗补助覆盖范围和州级交付方法对成人糖尿病患者的医疗质量、结果和成本的影响
- 批准号:
10627903 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别:
Health and Economic Impacts of Coverage Requirements and Health System-Community Coordination for Diabetes Prevention
覆盖要求和卫生系统社区协调对糖尿病预防的健康和经济影响
- 批准号:
9924263 - 财政年份:2017
- 资助金额:
$ 44.62万 - 项目类别:
相似海外基金
Spillover Effects of Medicaid Dental Coverage Expansions on Health Status
医疗补助牙科覆盖范围扩大对健康状况的溢出效应
- 批准号:
10590847 - 财政年份:2023
- 资助金额:
$ 44.62万 - 项目类别:
Longitudinal Examination of Changes in Medicaid Adult Dental Coverage and Spillover Effects on Children
医疗补助成人牙科覆盖范围的变化和对儿童的溢出效应的纵向研究
- 批准号:
10592152 - 财政年份:2023
- 资助金额:
$ 44.62万 - 项目类别:
The Effects of the Medicaid Continuous Coverage Requirement during the Public Health Emergency on Postpartum Coverage and Maternal and Infant Care after Childbirth
突发公共卫生事件期间医疗补助持续覆盖要求对产后覆盖和产后母婴护理的影响
- 批准号:
10643130 - 财政年份:2023
- 资助金额:
$ 44.62万 - 项目类别:
Integrating Medicare and Medicaid coverage in managed care: effects on quality, utilization, and disparities
将医疗保险和医疗补助覆盖纳入管理式医疗:对质量、利用率和差异的影响
- 批准号:
10710744 - 财政年份:2023
- 资助金额:
$ 44.62万 - 项目类别:
Policy effects on gender minority health and evidence from the implementation of gender affirming coverage in Medicaid
对性别少数群体健康的政策影响以及医疗补助中性别肯定覆盖实施的证据
- 批准号:
10584754 - 财政年份:2022
- 资助金额:
$ 44.62万 - 项目类别:
The Medicaid expansion in the age of COVID-19: Effects on coverage, access, use, financial stress, and health.
COVID-19 时代医疗补助的扩展:对覆盖范围、获取、使用、财务压力和健康的影响。
- 批准号:
10363920 - 财政年份:2021
- 资助金额:
$ 44.62万 - 项目类别:
The Medicaid expansion in the age of COVID-19: Effects on coverage, access, use, financial stress, and health.
COVID-19 时代医疗补助的扩展:对覆盖范围、获取、使用、财务压力和健康的影响。
- 批准号:
10488212 - 财政年份:2021
- 资助金额:
$ 44.62万 - 项目类别:
The Medicaid expansion in the age of COVID-19: Effects on coverage, access, use, financial stress, and health.
COVID-19 时代医疗补助的扩展:对覆盖范围、获取、使用、财务压力和健康的影响。
- 批准号:
10685303 - 财政年份:2021
- 资助金额:
$ 44.62万 - 项目类别:
Effects of Medicaid Coverage and State-Level Delivery Approaches on Healthcare Quality, Outcomes, and Costs for Adults with Diabetes
医疗补助覆盖范围和州级交付方法对成人糖尿病患者的医疗质量、结果和成本的影响
- 批准号:
10223857 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别:
Effects of Medicaid Coverage and State-Level Delivery Approaches on Healthcare Quality, Outcomes, and Costs for Adults with Diabetes
医疗补助覆盖范围和州级交付方法对成人糖尿病患者的医疗质量、结果和成本的影响
- 批准号:
10627903 - 财政年份:2020
- 资助金额:
$ 44.62万 - 项目类别: